RELATED: Novartis sharpens focus on vision-restoring gene therapy with $150M Vedere buyout. Cadent emerged from stealth in November 2018 ...
https://www.google.com/url?rct=j&sa=t&url=https://www.fiercebiotech.com/biotech/novartis-snaps-up-neuro-partner-cadent-for-210m-upfront-promise-up-to-560m-more&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNHvUtI6NiQ7G1xcwfcF5cJPdzA2nw
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.